000			03670nam a22005897a 4500
008			160113s20142014 xxu||||| |||| 00| 0 eng d
022			_a0896-4327
040			_aOvid MEDLINE(R)
099			_a24447166
245			_aIncidence and correlates in the development of iatrogenic femoral pseudoaneurysm after percutaneous coronary interventions.
251			_aJournal of Interventional Cardiology. 27(2):212-6, 2014 Apr.
252			_aJ. INTERVENT. CARDIOL.. 27(2):212-6, 2014 Apr.
253			_aJournal of interventional cardiology
260			_c2014
260			_fFY2014
266			_d2016-01-13
520			_aBACKGROUND: IFP is one of the more common vascular complications of PCI.
520			_aCONCLUSION: The development of IFP following PCI is not uncommon and the appropriate use of vascular closure devices to achieve hemostasis should be encouraged to minimize this vascular complication.Copyright � 2014, Wiley Periodicals, Inc.
520			_aMETHODS: From February 2008 to June 2012, 10,169 consecutive patients who underwent PCI were retrospectively studied. Patients who developed postprocedural IFP were identified at a single, large tertiary PCI center.
520			_aOBJECTIVE: We aimed to identify the correlates in the development of post-percutaneous coronary intervention (PCI) iatrogenic femoral pseudoaneurysm (IFP).
520			_aRESULTS: One hundred thirty-nine patients developed IFP (1.38%) and were compared to the cohort that did not. Baseline characteristics were comparable, although patients in the IFP group were older and had a higher incidence of insulin-requiring diabetes mellitus and chronic renal insufficiency (68.4+/-12.9 vs. 65.4+/-12.3 years, P=0.004; 23.9% vs. 14.6%, P=0.002; and 26.6% vs. 17.3%, P=0.004, respectively). The non-IFP group had more men and a higher use of vascular closure devices, respectively (64.7% vs. 49.6%, P<0.001; and 54.1% vs. 26.5%, P<0.001). There was no significant difference in the use of dual antiplatelet or anticoagulation therapies between the 2 cohorts. Univariable correlates for the development of IFP were female gender, insulin-requiring diabetes mellitus, chronic renal insufficiency, and use of manual compression to achieve hemostasis. On multivariable analysis, the successful deployment of vascular closure device for hemostasis reduced the occurrence of IFP (odds ratio 0.31, 95% confidence interval 0.21-0.46, P<0.0001).
546			_aEnglish
650			_a*Aneurysm, False/et [Etiology]
650			_a*Femoral Artery
650			_a*Iatrogenic Disease
650			_a*Percutaneous Coronary Intervention
650			_aAged
650			_aAneurysm, False/ep [Epidemiology]
650			_aDiabetes Mellitus, Type 1/co [Complications]
650			_aFemale
650			_aHemostasis
650			_aHumans
650			_aIatrogenic Disease/ep [Epidemiology]
650			_aMale
650			_aPercutaneous Coronary Intervention/mt [Methods]
650			_aPostoperative Complications
650			_aRenal Insufficiency, Chronic/co [Complications]
651			_aMedStar Heart & Vascular Institute
657			_aJournal Article
700			_aBadr, Salem
700			_aBernardo, Nelson L
700			_aChen, Fang
700			_aKitabata, Hironori
700			_aPichard, Augusto D
700			_aSatler, Lowell F
700			_aSuddath, William O
700			_aTorguson, Rebecca
700			_aWaksman, Ron
790			_aBadr S, Bernardo NL, Chen F, Kitabata H, Pichard AD, Satler LF, Suddath WO, Torguson R, Waksman R
856			_uhttp://dx.doi.org/10.1111/joic.12091 _zhttp://dx.doi.org/10.1111/joic.12091
942			_cART _dArticle
999			_c1043 _d1043